一个为所有,所有为一个:对推动MYC失调的增强者的新见解 MYC失调
Roger Mulet-Lazaro1,2, Ruud Delwel1,2
1Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Blood cancer discovery
|April 16, 2025
概括
研究人员使用CRISPR干扰幕确定了驱动淋巴瘤中MYC过度表达的关键调控元素. 一种控制生殖中心重新进入的新型MYC增强剂在扩散的大B细胞淋巴瘤中被发现被放大.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 原型瘤基因MYC是已知的淋巴瘤驱动因素.
- 淋巴瘤中MYC失调的机制仍然不完全理解.
研究的目的:
- 为了确定对淋巴瘤中MYC过度表达至关重要的增强剂.
- 为了在MYC场地内发现新的监管元素.
主要方法:
- CRISPR干扰 (CRISPRi) 屏幕针对的是开放的染色体区域.
- 分析淋巴瘤的调节因素,特别是扩散型大B细胞淋巴瘤 (DLBCL).
主要成果:
- 确定对MYC过度表达至关重要的增强剂.
- 在MYC locus.中发现了一个新的监管元素.
- 这个元素控制了生殖中心的重新进入,并在生殖中心B细胞DLBCL中得到放大.
结论:
- 这项研究阐明了MYC在淋巴瘤中的新型调节机制.
- 这些发现突出了DLBCL的潜在治疗目标.
相关概念视频
Induced Pluripotent Stem Cells
3.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K


